Elevance Health, Inc. 10-K — AI Bull & Bear Analysis

The 2025 10-K presents a company in the midst of a high-stakes identity shift. Elevance is attempting to trade the volatility of a pure-play insurer for the stability of a healthcare infrastructure provider. While the growth in Carelon's fee-based revenue is a positive signal, the transition is being financed through significant leverage and a heavy reliance on the continued stability of its BCBSA licenses. Ultimately, the investment case hinges on whether the operational leverage from vertical integration can outpace the rising cost of debt and the inherent risks of the Medicaid and Medicare Advantage markets. The company's ability to maintain its fortress balance sheet while navigating complex regulatory and antitrust challenges will be the primary determinant of its long-term success.